BAMBUSA THERAPEUTICS

Serial Number 98752279
686

Registration Progress

Application Filed
Sep 16, 2024
Under Examination
Approved for Publication
Jun 17, 2025
Published for Opposition
Jun 17, 2025
Registered

Basic Information

Serial Number
98752279
Filing Date
September 16, 2024
Published for Opposition
June 17, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
Jun 17, 2025
Application
Pending
Classes
005

Rights Holder

Bambusa Therapeutics, Inc.

03
Address
5 Fan Pier Boulevard
Apartment 2024
Boston, MA 02210

Ownership History

Bambusa Therapeutics, Inc.

Original Applicant
03
Boston, MA

Bambusa Therapeutics, Inc.

Original Applicant
03
Boston, MA

Bambusa Therapeutics, Inc.

Owner at Publication
03
Boston, MA

Bambusa Therapeutics, Inc.

Owner at Publication
03
Boston, MA

Legal Representation

Attorney
Ilene B. Tannen

Application History

32 events
Date Code Type Description
Jun 23, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 23, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 23, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 23, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 23, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 23, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 17, 2025 PUBO A PUBLISHED FOR OPPOSITION
Jun 17, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 17, 2025 PUBO A PUBLISHED FOR OPPOSITION
Jun 17, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 11, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 11, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 15, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
May 15, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
May 1, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
May 1, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 1, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
May 1, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
May 1, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 1, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 24, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 24, 2025 CNRT R NON-FINAL ACTION WRITTEN
Mar 24, 2025 GNRT F NON-FINAL ACTION E-MAILED
Mar 24, 2025 DOCK D ASSIGNED TO EXAMINER
Mar 24, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 24, 2025 CNRT R NON-FINAL ACTION WRITTEN
Mar 24, 2025 GNRT F NON-FINAL ACTION E-MAILED
Mar 24, 2025 DOCK D ASSIGNED TO EXAMINER
Mar 23, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 23, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 16, 2024 NWAP I NEW APPLICATION ENTERED
Sep 16, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of inflammatory and immunological diseases and disorders for human use

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"
Specific Disclaimer
"THERAPEUTICS"